You haven't searched anything yet.
Director, Clinical Operations – Inflammation
Location: Boston, MA
Monte Rosa Therapeutics is seeking a highly experienced Clinical Operations professional to lead the successful planning, implementation, and conduct of clinical trials across multiple indications. Reporting to the Head of Clinical Operations, the Director, Clinical Operations will be responsible and accountable for development of operational program strategy and leading execution of First in Human through Phase III trials depending on program lifecycle, representing clinical operations on cross functional Core Teams, and managing clinical operations team members to ensure adherence with overall study timelines, budget, quality, and regulatory standards (ICH/GCP, internal SOPs). A genuine interest and understanding of the science supporting the MRT pipeline, an ability to work in a multidisciplinary team setting, and a commitment to developing new treatments for patients are critical for success.
Key Responsibilities:
Skills & Qualifications
Interested Candidates may forward CV and Cover Letter letting us know your area of interest please forward to Careers-US@MonterosaTx.com
Monte Rosa Therapeutics (MRT) is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. MGDs are small molecule protein degraders that have the potential to treat many diseases that other modalities, including other degraders, cannot. Monte Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology, and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs, which spans oncology, autoimmune and inflammatory disease and beyond, and has a strategic collaboration with Roche to discover and develop MGDs against targets in cancer and neurological diseases previously considered impossible to drug.
Full Time
$130k-170k (estimate)
06/23/2024
07/10/2024
monterosatx.com
Brighton, MA
<25